←
Hyeon6,597 posts
Hyeon avatar

Hyeon

@hyeon__dev

growth @qfex

◷ Joined October 2021▧ 630 Photos and videos
Hyeon avatar
Hyeon@hyeon__dev·Aug 7

One thing I’ve noticed from trading more actively is how quickly market narratives turn over. Themes used to have real staying power. Now the market can move on within weeks. I’m not sure how much of this is driven by AI, but the pattern is hard to miss: software gets sold at a record pace, attention shifts to high-short-interest names, and everyone is already searching for the next bottleneck or story. According to J.P. Morgan, weekly retail outflows from software and services recently hit their highest level since the data series began. At the same time, social-media interest was clustering around high short interest names like GRND, RH, NBIS, and CAKE, alongside memory, AI infrastructure, and space names like SNDK, MU, VRT, and RKLB. It doesn’t feel like capital is rotating neatly from one theme to the next. It feels more like several stories are lighting up and burning out at once. Sometimes the entire market seems to trade like a meme. Positions don’t stay in one place for long, while social media and AI have shortened the gap between discovering a narrative, spreading it, and exhausting it. But a discarded theme bouncing back doesn’t mean it has reclaimed the center of the market. If earnings estimates keep rising and capital continues to flow in, it may still be a trending asset. If the move is driven mainly by short covering, an event, or a sudden spike in attention, it is probably still a trade. SpaceX holding up despite a large lockup expiry may be another example. Maybe less stock was sold than expected. Or maybe the market had already moved past the unlock and started pricing in the next story. In a market where narratives have shorter shelf lives, finding a good story is no longer enough. The harder question is whether it is still a trend, or whether it has already become just another trade. The Shortening Shelf Life of Market Narratives

MetaMask 한국 avatar
⟳ Hyeon retweeted
MetaMask 한국@metamask_kr·8h

메타마스크 창업자 조셉 루빈과 대한미국인 타일러가 만났습니다 🦊 @ethereumJoseph @tylerrasch 달러 시스템의 한계부터 은행이 멈추는 주말에 내 돈은 어떻게 되는지, 그리고 AI 에이전트가 자산을 관리하는 미래까지. 탈중앙화 금융이 왜 중요한지 두 편에 걸쳐 이야기를 나눴습니다. 👉 원빅월드쇼 채널에서 지금 확인해보세요!

Post attachment
Hyeon avatar
Hyeon@hyeon__dev·Nov 17

The More Everyone Builds an Everything App, the Narrower Your Starting Point Should Be Financial and crypto apps are increasingly moving in the same direction. Robinhood started with stocks and is now expanding into crypto and prediction markets. Polymarket and Kalshi began with prediction markets but are moving toward stocks and derivatives. Coinbase and Kraken are also trying to grow beyond spot trading by adding perps, prediction markets, memecoins, and onchain assets. MetaMask is also moving toward becoming an all in one wallet by integrating various features. Everyone seems to be building an “everything app” for trading and investing. The strategy makes sense for platforms that already have distribution. Every new product gives existing users another reason to stay, while shared balances, collateral, and liquidity make the overall platform more useful. It also expands monetization beyond trading fees into lending, payments, custody, rewards, and other financial services. But as the feature sets begin to converge, the real competition may move elsewhere: - Do users trust the platform enough to keep their assets there? - Does it have a strong incentive system for both new users and whales? - Can balances and collateral actually work across different products? - Is there any reason for a user to leave once they are inside? An everything app is rarely built by launching everything at once. It is usually the end result of earning users through one strong entry point and then expanding that relationship. That is why a new consumer startup may need to take the opposite approach. Instead of building another app for everyone who trades stocks, crypto, and prediction markets, it may be better to solve one specific problem for one specific type of user, en times better than existing products do. “Traders” is still too broad. A better starting point might be people who move positions based on funding rates, users who repeatedly trade a particular niche market, or teams that need to manage collateral and risk across multiple venues. A niche market does not necessarily mean a small market. It can be an entry point into a group of users that larger platforms still treat as one generic segment. The everything app may be the destination, but it does not need to be the starting point. When everyone else is bundling features, the best new opportunities may come from unbundling a narrow problem that no one has solved properly yet.

everybody is trying to become the everything app robinhood started with stocks and now is integrating prediction markets & crypto polymarket/kalshi started with prediction markets & now integrating perps & stocks coinbase/kraken started with crypto spot trading & now integrating perps, prediction markets, & memecoins/onchain pump started as a memecoin launchpad & now integrating crosschain trading, perps, prediction markets it seems like whoever has • stickiest customer retention • best rev-sharing systems for new users & whales • cross margining across the stack will win this game dont really have strong thesis on how best to differentiate from others here, also asked this question at the end of coinbase's last earnings call

Hyeon avatar
Hyeon@hyeon__dev·Nov 15

As crypto prices keep falling, most narratives are losing momentum with them. But if this cycle is not completely over, the next rotation may begin in sectors that have already demonstrated real demand. One of the most durable themes this cycle has been revenue: products generate fees, and part of those fees flows back into buying the token. That is why Derive may be worth revisiting, especially as onchain options tend to return to the conversation whenever market volatility rises. According to completed DeFiLlama data through November 13, Derive generated roughly $151K in fees over the previous seven days, up 18.5% from the week before. 30day fees reached $573K, with approximately 75% coming from options. This matters because options are no longer just producing a trading-volume narrative for Derive. They have become the protocol’s primary fee-generating product. The more interesting question is how that revenue connects to DRV. Derive currently uses 50% of eligible fees to purchase DRV from the market each week. The remaining 50% goes into an onchain insurance fund. The buyback share was previously 35%, but the DAO voted to raise it in anticipation of more fee-generating products following the V3 launch. The new 50% allocation took effect on October 14. If 50% of the last 30 days’ fees continued at the same pace, the simple annualized buyback budget would be approximately $3.5M. That equals roughly: 1.3% of DRV’s circulating market cap 0.9% of its FDV This is real market buying pressure, but it is not yet large enough to support the token price on its own. There is another important limitation: the purchased DRV is held in the DAO wallet rather than burned. It therefore does not permanently remove supply in the same way a token burn would. That is why “the protocol has revenue and conducts buybacks” is not enough. A revenue-token thesis should answer three questions: 1. Is revenue sustainable and growing? 2. What percentage actually funds buybacks? 3. Is the resulting demand meaningful relative to market cap and future dilution? Derive is beginning to show concrete numbers for the first two. The next things to watch are whether the buyback becomes material at DRV’s valuation and what the DAO ultimately does with the tokens it accumulates. Increasing the allocation from 35% to 50% shows that Derive has already started adjusting its value capture mechanism. The more meaningful signal would be another step: stronger buybacks, clearer treatment of DAO-held DRV, or another mechanism that gives protocol growth a more durable connection to the token. That is when the story becomes more than “Derive generates revenue.”

Derive is tracking for our 3rd biggest week of fees in the last year - crazy that a year ago we were putting up $20k in fees a week and now we are regularly hitting 30-40k per day. Taker base has diversified significantly in the last two months, both in terms of assets traded (BTC, ETH, HYPE, ZEC, SOL) and unique users. Retention numbers have also been very encouraging. Derive's maker base has also expanded dramatically post v3 with the dramatically simpler onboarding flow and upswing in taker activity. Further, we are now closing in on a few critical integrations going live that have been months/years in the making, and the quality and breadth of assets you can trade on Derive are about to see another step change. We continue to welcome all the feedback you can give us. Have a great weekend everybody.

Post attachment
Hyeon avatar
Hyeon@hyeon__dev·Nov 15

With narrative cycles compressing, picking what technology to back is no longer enough. Knowing where the market sits in the cycle and timing portfolio entry/exit is now an existential first order strategy for investors. Reflecting on this, I feel my personal edge lies firmly in Stages 1 & 2, that discovering early seeds and helping navigate the rising consensus wave. Sharpening those specific muscles is going to be my key focus moving forward. What phase of the cycle do you feel most at home investing in?

Hyeon avatar
Hyeon@hyeon__dev·Nov 15

1. The Obscurity Phase (Early) - Market: Minimal hype, high market education cost. - Investor Role: Category kingmaking. Backing early Schelling Point Companies, helping build idea moats, and providing long runways for high conviction bets. 2. Rising Conviction & Consensus - Market: Crowded, fast followers entering. - Investor Role: Filtering out "central casting" clones. Connecting portfolio networks to gather real market feedback and spot micro narratives. 3. Peak Fervor & Euphoria - Market: Maximum hype, excess capital, noise. - Investor Role: Guarding against valuation risk. Rigorously auditing whether a company has a meaningfully differentiated product or massive distribution. 4. Rise from the Ashes - Market: Cynicism, disillusionment, reset expectations. - Investor Role: Contrarian betting. Finding "phoenix" founders who turn past failures into a foundational prequel.

Hyeon avatar
Hyeon@hyeon__dev·Nov 15

Found this incredible piece by Michael Dempsey (Narrative Cycle Entry) on how tech startups move through narrative cycles. Even though it was written a while ago, it feels more relevant than ever given how compressed these cycles have become. A quick breakdown of the investor's playbook across the 4 stages

Post attachment
smac@0xsmacNov 14

probably a decent time to revisit this michaeldempsey.me/blog/2025/…

Hyeon avatar
Hyeon@hyeon__dev·Nov 15

Trust relationships are becoming the new bottleneck inside companies. Hiring one more employee or connecting one more SaaS tool is no longer just a productivity investment. It creates another trust relationship the company may need to manage for years. An employee needs more than email and Slack. Someone must decide how much access they receive to GitHub, cloud infrastructure, databases, customer data, and internal documents. That trust also extends to personal devices, browser extensions, API keys, and whether every permission is actually revoked when they leave. External software creates the same problem. Connecting a SaaS product may save months of development, but it also introduces OAuth permissions, API keys, webhooks, copied data, vendor dependencies, and exposure to someone else’s software supply chain and incident response. The real issue is that these connections rarely disappear. A tool added for one small feature gradually becomes critical infrastructure. An employee’s temporary access becomes permanent. Over time, companies accumulate hundreds of relationships without a clear view of who can access what, where data is being replicated, or which dependency could become the next point of failure. So the scaling question is no longer just: How many people and tools can we add? It is: How many trust relationships can we continuously verify, constrain, monitor, and revoke? The next enterprise security bottleneck may not be a lack of tools. It may be the growing trust surface created by all of them.

Hyeon avatar
Hyeon@hyeon__dev·Nov 15

Another fact: Hyperliquid and Lighter were launched when BTC was above $80K

Post attachment

Interesting fact: All perp DEXs in 2026 that have launched or are planning their TGEs are doing so with BTC below $70K

Post attachment
Hyeon avatar
Hyeon@hyeon__dev·Nov 14

Stablecoin supply may be the wrong KPI for stablecoin adoption. Tulip King raised a good question under Mason Nystrom’s post about Visa’s growing stablecoin activity: If stablecoins are seeing so much corporate adoption, why has total supply declined over the past year? Why is the market still nowhere near the multi-trillion-dollar projections? Mason’s explanation was that stablecoin supply is still heavily tied to crypto trading. When crypto prices and trading activity weaken, fewer dollars flow into exchanges and less new stablecoin supply is issued. That can suppress supply and CEX transfer volume even while other use cases that payments, remittances, cards and treasury operations, continue to grow. Visa, for example, says its stablecoin settlement run rate has surpassed $25 billion annually, while the number of stablecoin-linked card programs has reached 225 across more than 50 countries. Tulip then suggested another explanation: perhaps onchain dollars are structurally more capital efficient. Traditional financial systems require money to remain prefunded or idle while transactions take days to settle. Stablecoins can settle and be reused much faster. If the same dollar can support more transactions within the same period, economic activity can grow without an equivalent increase in outstanding supply. The question is no longer just how many stablecoins exist. It is how much real economic activity each stablecoin dollar supports. That said, this shift in perspective still comes with important caveats. The majority of on chain stablecoin volume remains tied to trading, liquidity management, and internal transfers rather than actual payments for goods and services. Raw transfer figures can be misleading; filtered data (such as Visa/Allium style adjustments that strip out bots, flash loans, and exchange rebalancing) is necessary to isolate genuine economic activity. It is how much real economic activity each stablecoin dollar supports.

Why do you think stablecoin supply is down in the last ~yr & growth overall sucks? Bessent promised us like $3t in stables and we’re nowhere close. Genuine question because it’s absolutely eating at me, I cannot make sense of the difference between reality and consistent bull posting by corporates

Hyeon avatar
Hyeon@hyeon__dev·Nov 13

Do operations & finance-led CEOs hurt tech stocks? Across six selected tech CEO transitions, the first year results were evenly split: three stocks rose and three fell; three beat the S&P 500 and three lagged it. The lesson isn’t that non-technical CEOs fail. It’s that during major technology shifts, product and process judgment must not be subordinated to short term earnings and cost cutting. Tim Cook succeeded by preserving Apple’s product leadership while adding operational scale. The real question is whether a CEO knows what matters technically and backs the people who do. Which raises another question: What happens to $NVDA when Jensen Huang eventually steps down?

Post attachmentPost attachment
Hyeon avatar
Hyeon@hyeon__dev·Nov 12

My gun was too powerful - Huang

Post attachment

9) $NVDA CEO Huang has walked alongside Megaspeed at every step, and seems to have a close relationship with Megaspeed's Alice Huang. They partied together in June 2024 - same month as the Apex/Alibaba pledge, then dined together in May 2025 - just after U.S. trade restrictions.

Post attachmentPost attachmentPost attachment
Hyeon avatar
Hyeon@hyeon__dev·Nov 11

Will it rise after the NBIS earnings announcement tomorrow?

Post attachment
Hyeon avatar
Hyeon@hyeon__dev·Nov 11

Eli Lilly has been on a strong run lately. I went through some of the recent news to understand what may be driving the stock. There has been a steady stream of positive developments from earnings and clinical data to regulatory approvals and new partnerships. Here are five updates worth knowing: 1. Next-generation LNP delivery partnership with METiS TechBio Lilly is partnering with METiS TechBio to develop next generation lipid nanoparticle delivery systems using METiS’ AI powered platform. The deal includes a low teens million dollar upfront payment and up to $1.1 billion in potential milestone payments. This is unlikely to move near term earnings, but it gives Lilly access to delivery technology that could eventually support RNA and gene therapies that expanding the company’s pipeline without requiring a large upfront commitment. 2. Mounjaro and Zepbound are driving another guidance raise Lilly reported 3th quarter revenue of $24.4 billion, up 39% year over year. - Mounjaro: $10.7 billion - Zepbound: $5.3 billion The company raised the midpoint of its full-year revenue guidance by approximately $5.5 billion. There were some one-time effects and lower realized pricing, but prescription volume continues to translate into substantial revenue growth. This remains the clearest near term driver of Lilly’s fundamentals. 3. Retatrutide outperformed semaglutide in Phase 3 At week 80, retatrutide produced average weight loss of 19.5% to 20.9%, compared with 9.4% for semaglutide 2.0 mg. Retatrutide also delivered a greater reduction in HbA1c, strengthening its potential as Lilly’s next major obesity and diabetes treatment. The trade off is tolerability: discontinuation rates due to adverse events were higher in the high dose retatrutide groups. The efficacy is impressive, but safety and tolerability still need to be watched. 4. Obesity drugs are expanding into related diseases In a Phase 3 knee osteoarthritis trial presented at ACR, retatrutide reduced pain by as much as 73% to 76%. This supports a broader thesis: obesity drugs may expand beyond weight loss into conditions such as osteoarthritis and sleep apnea. If approved for additional indications, these therapies could reach more patients, receive broader insurance coverage, and significantly expand their addressable markets. 5. Lilly is already building the next obesity drug portfolio EloraTZP achieved up to 23.3% weight loss at week 48 in Phase 2, compared with 14.8% for tirzepatide alone. At the same time, Mounjaro has received an expanded FDA indication for reducing cardiovascular risk. Lilly is therefore pursuing both sides of the strategy: expanding the market for its current products while developing the therapies that could eventually succeed them. The bigger picture Mounjaro and Zepbound are driving Lilly’s earnings today. Retatrutide, EloraTZP, new indications, and delivery platform partnerships are building the company’s next phase of growth. Not every announcement has the same near-term financial impact, but taken together, Lilly currently has something investors rarely see at this scale: strong present day execution and multiple credible long-term growth engines at the same time. That combination may help explain the stock’s recent strength.

Post attachment
Hyeon avatar
Hyeon@hyeon__dev·Nov 10

Can Bitcoin reclaim the market leadership it lost to the AI trade? Since the launch of ChatGPT, AI has been one of the strongest themes priced into global markets. NVIDIA became the clearest publicly traded expression of compute scarcity, benefiting directly from the expansion of AI infrastructure. Bitcoin, which had previously served as a leading expression of liquidity, technological optimism, and digital scarcity, began to lag behind. So I compared BTC directly with NVDA. This is not an attempt to value a company and a digital asset on the same basis. Instead, the ratio offers a way to observe whether the market has been willing to pay more for digital scarcity or compute scarcity and whether that preference is beginning to change. I divided the BTC price by NVIDIA’s adjusted share price and normalized the ratio to 100 on November 30, 2022, the day ChatGPT launched. - August 2026 low: 27.4 - Current provisional reading: 41.0 - Rebound from the low: +49.3% - Versus the ChatGPT launch baseline: -59.0% - Increase required to recover the 2025 relative-strength high: +127% The ratio has rebounded meaningfully from its August low. But it is still too early to say Bitcoin has reversed several years of relative underperformance against NVIDIA. If NVIDIA’s share price remained unchanged, Bitcoin would need to reach approximately $169,000 for the ratio to recover its 2025 high. The reason I built this indicator is to track whether market preference and potentially capital is beginning to rotate away from the AI trade and back toward crypto. Can Bitcoin recover the spring it lost during the AI summer?

Post attachment